CSTL CASTLE BIOSCIENCES INC

Ownership history in Birchview Capital, LP  ·  9 quarters on record

This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in CASTLE BIOSCIENCES INC (CSTL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.24% (2025 Q2)
Avg. % of fund
1.31%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 80,600 -30,000 -27.1% 1.84% $3.1M $38.90
2025 Q3 UNCHANGED 110,600 0% 1.90% $2.5M $22.77
2025 Q2 ADDED 110,600 +22,196 +25.1% 2.24% $2.3M $20.42
2025 Q1 ADDED 88,404 +10,404 +13.3% 1.54% $1.8M $20.02
2024 Q4 ADDED 78,000 +20,000 +34.5% 1.69% $2.1M $26.65
2024 Q3 ADDED 58,000 +24,000 +70.6% 1.44% $1.7M $28.52
2024 Q2 ADDED 34,000 +20,000 +142.9% 0.69% $740K $21.77
2024 Q1 ADDED 14,000 +4,000 +40.0% 0.25% $310K $22.15
2023 Q4 INITIATED 10,000 0.17% $216K
% of Fund (quarterly)    CSTL price (monthly, adj. close)
← Back to Birchview Capital, LP Holdings